Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-30 00:33:19 - browse：76

Emma Walmsley on stage at the 2023 STAT Summit. — GSK CEO Emma Walmsley at the 2023 STAT Summit. STAT

The story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a pure-play biopharma company dedicated to the prevention, as well as treatment, of disease.

GSK’s recent launch of a new RSV vaccine for adults is emblematic of this move, adding to a portfolio that includes other vaccines, such as the very successful Shingrix for shingles, as well as drugs for HIV, other infectious diseases, and cancer, among others. But what does the growing sentiment against vaccination, not just in the United States but around the world, mean for such a bet on this market?

“It’s a very, very serious issue,” Walmsley said, noting that in 11 U.S. states, basic vaccination rates are now lower than they were before Covid. “The answer can’t be sort of flinging science over the airwaves and saying ‘trust us,’ because people don’t. There is a really serious challenge of misinformation and the ongoing issue of politicization, which I suspect is going to get more challenging in the next year for obvious reasons.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： David Liu startup to focus on CRISPR delivery

focus

WSS

AstraZeneca chief proposes a novel edit to the drug pricing bill

Stem cell treatment guidelines are released by FDA

Assistant physicians can help address the primary care shortage

Fed up with FDA, ALS advocates consider a take

ALS advocates say criticism of new drugs misses bigger picture

House transparency, PBM reform bill gains bipartisan support

hotspot

Wikipedia

hotspot

Cancer drug shortages should be causing more outrage

A rare thyroid diagnosis led to unexpected, all

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The 10 drugs up first for Medicare price negotiation

Medical records are filled with copy

White House Covid adviser calls on docs to combat misinformation

Moonlake's readout produced a cash windfall. Risks remain

Fed up with FDA, ALS advocates consider a take

Guidelines to prevent youth baseball injuries need more muscle

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

knowledge

What American doctors can learn from their Israeli counterparts

Why Novartis is changing the name of its research labs

How to fix cancer clinical trials' diversity problem

FDA weighs limits of animal data in assessing artificial wombs

The struggle to figure out which patients 'deserve' Wegovy

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

focus

Wikipedia

explore

explore